Understand if your compound is an inhibitor of carboxylesterases.
Carboxylesterase (CE) inhibition is a non-CYP mediated metabolism assay within our portfolio of in vitro ADME screening services. Cyprotex deliver consistent, high quality data with the flexibility to adapt protocols based on specific customer requirements.
CE inhibitors potentially have dual roles in modulating drug action, by both reducing induced toxicity and/or increasing molecule half-life.
1Hatfield M.J. and Potter P.M. (2011) Expert Opin Ther Pat 21(8); 1159-1171
|Test System||hCE1-b and/or hCE1-c expressed enzymes|
|Test Article Concentrations||0, 0.4, 1, 4, 10, 40 and 100 µM (different concentrations available)|
|Positive Control Inhibitors||Benzil (hCE1)|
|Test Article Requirements||100 µL of a 40 mM DMSO solution (or equivalent amount in solid)|
Standard error of IC50
% Control at each concentration
1Hatfield MJ and Potter PM (2011) Carboxylesterase inhibitors. Expert Opin Ther Pat 21(8); 1159-1171
Learn more about drug metabolism in chapter 3 of our popular Everything you need to know about ADME guide.
Europe: +44 (0)1625 505100
North America (East Coast): +1-888-297-7683